CohBar Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Share Price
  • $0.41
  • (As of Monday Closing)

CohBar General Information

Description

CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria-based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drugs such as CB4209 and CB4211, SHLP-6, SHLP-2, and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operations of the group functioned through the region of the United States.

Contact Information

Website
www.cohbar.com
Formerly Known As
Menlo Park
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1455 Adams Drive
  • Suite 1308
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1455 Adams Drive
  • Suite 1308
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CohBar Stock Performance

As of 06-Jan-2025, CohBar’s stock price is $0.41. Its current market cap is $1.19M.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.41 $0.41 $1.19M 4.29K

CohBar Financials Summary

As of 30-Jun-2023, CohBar has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV (5,971) (13,413) 15,458 62,132
Revenue 0 0 0 0
EBITDA (13,028) (12,287) (15,307) (15,334)
Net Income (12,687) (12,175) (15,476) (16,265)
Total Assets 12,506 16,366 27,296 21,908
Total Debt 0 0 366 698
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CohBar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CohBar‘s full profile, request access.

Request a free trial

CohBar Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore CohBar‘s full profile, request access.

Request a free trial

CohBar Patents

CohBar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230372434-A1 Method of treating fibrosis with a combination therapy Pending 21-Oct-2020
EP-4135738-A2 Method of treating coronavirus infections Inactive 15-Apr-2020
US-20230218710-A1 Method of treating coronavirus infections Pending 15-Apr-2020
US-20240034753-A1 Therapeutic peptides Pending 29-Jan-2020
US-20220395553-A1 Cxcr4 antagonist peptides Pending 14-Nov-2019 C07K14/7158
To view CohBar’s complete patent history, request access »

CohBar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CohBar ESG

Risk Overview

Risk Rating

Updated October, 22, 2020

36.44 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,042

Rank

Percentile

Pharmaceuticals

Industry

of 947

Rank

Percentile

Biotechnology

Subindustry

of 427

Rank

Percentile

To view CohBar’s complete esg history, request access »

CohBar FAQs

  • When was CohBar founded?

    CohBar was founded in 2007.

  • Where is CohBar headquartered?

    CohBar is headquartered in Menlo Park, CA.

  • What is the size of CohBar?

    CohBar has 10 total employees.

  • What industry is CohBar in?

    CohBar’s primary industry is Biotechnology.

  • Is CohBar a private or public company?

    CohBar is a Public company.

  • What is the current stock price of CohBar?

    As of 06-Jan-2025 the stock price of CohBar is $0.41.

  • What is the current market cap of CohBar?

    The current market capitalization of CohBar is $1.19M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »